Source: American Journal of Clinical Oncology. Unidade: FM
Assunto: ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KATZ, A et al. Phase ii trial of etoposide (v), adriamycin (a), and cisplatinum (p) in patients with metastatic gastric cancer. American Journal of Clinical Oncology, v. 14, n. 4 , p. 357-8, 1991Tradução . . Acesso em: 13 ago. 2024.APA
Katz, A., Gansl, R. C., Simon, S. D., Gama Rodrigues, J. J., Waitzberg, D. L., Bresciani, C. J. C., & Pinotti, H. W. (1991). Phase ii trial of etoposide (v), adriamycin (a), and cisplatinum (p) in patients with metastatic gastric cancer. American Journal of Clinical Oncology, 14( 4 ), 357-8.NLM
Katz A, Gansl RC, Simon SD, Gama Rodrigues JJ, Waitzberg DL, Bresciani CJC, Pinotti HW. Phase ii trial of etoposide (v), adriamycin (a), and cisplatinum (p) in patients with metastatic gastric cancer. American Journal of Clinical Oncology. 1991 ;14( 4 ): 357-8.[citado 2024 ago. 13 ]Vancouver
Katz A, Gansl RC, Simon SD, Gama Rodrigues JJ, Waitzberg DL, Bresciani CJC, Pinotti HW. Phase ii trial of etoposide (v), adriamycin (a), and cisplatinum (p) in patients with metastatic gastric cancer. American Journal of Clinical Oncology. 1991 ;14( 4 ): 357-8.[citado 2024 ago. 13 ]
